Renovascular hypertension in children

Ramy Ghabril1

  • 1Department of Clinical Pediatrics & Pediatric Nephrology, Saint George University Hospital, University of Balamand, Beirut, Lebanon. dr.ramy@ghabril.com

Insights

Renovascular disease causes high blood pressure in children, but it is treatable. Prompt diagnosis and multidisciplinary care lead to good long-term outcomes for pediatric hypertension patients.

Area of Science:

  • Pediatric Nephrology
  • Vascular Medicine
  • Pediatric Hypertension

Background:

  • Renovascular disease is a significant cause of pediatric hypertension, accounting for 5-10% of cases.
  • This condition often presents with severe, difficult-to-control high blood pressure in children.
  • Despite its seriousness, renovascular disease is a potentially curable cause of hypertension.

Purpose of the Study:

  • To highlight the diagnostic gold standard for pediatric renovascular hypertension.
  • To outline the multidisciplinary treatment approaches for this condition.
  • To emphasize the potential for favorable long-term outcomes in affected children.

Main Methods:

  • Diagnosis relies on renal angiography as the established gold standard.
  • Treatment involves a combination of antihypertensive medications.
  • Interventional procedures such as angioplasty and surgical options are utilized.

Main Results:

  • High blood pressure in children with renovascular disease is typically severe and challenging to manage.
  • Renal angiography provides definitive diagnosis for renovascular hypertension.
  • Multidisciplinary team management ensures comprehensive care for affected children.

Conclusions:

  • Renovascular disease is a critical, yet curable, contributor to pediatric hypertension.
  • Early and accurate diagnosis via renal angiography is essential.
  • A coordinated approach involving pediatric nephrologists, interventional radiologists, and vascular surgeons improves long-term prognosis.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...